| WCMNX | WSMGX | WCMNX / WSMGX | |
| Total Expense Ratio | 1.24 | 1.10 | 113% |
| Annual Report Gross Expense Ratio | 2.04 | 1.77 | 115% |
| Fund Existence | 7 years | 30 years | - |
| Gain YTD | 15.203 | 23.657 | 64% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 54.6M | 25.2M | 217% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 19.43 | 31.68 | 61% |
| Returns for 3 years | 34.57 | 46.94 | 74% |
| Returns for 5 years | 3.31 | -28.56 | -12% |
| Returns for 10 years | N/A | 2.55 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTIX | 52.74 | 0.21 | +0.40% |
| Fidelity Advisor Biotechnology I | |||
| FBSIX | 42.25 | 0.16 | +0.38% |
| Franklin Mutual U.S. Mid Cap Value R6 | |||
| SDVGX | 18.84 | -0.05 | -0.26% |
| Sit Dividend Growth I | |||
| FSQIX | 13.35 | -0.04 | -0.30% |
| Fidelity Advisor Sustainable Intl Eq I | |||
| BGSRX | 83.42 | -0.26 | -0.31% |
| BlackRock Technology Opportunities R | |||